More importantly, our results showed that AIL-treated tumor supernatant inhibited Treg differentiation (Fig. 6 F-G) and Foxp3 expression (Fig. 6 H-I) more significantly after c-Jun overexpression, further suggesting that AIL indeed works by targeting c-Jun. The gene discussed is FOXP3; the disease is neoplasm.